Skip to content

Role of Homoeopathy in increased lipids

Effects of Individualized Homoeopathic intervention in dyslipidemia: An open label randomized controlled exploratory trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/12/005257
Enrollment
126
Registered
2014-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dyslipidemia

Interventions

Intervention1: Individualized homoeopathic medicine: Individualized homoeopathic treatment along with Life style modification shall be given to patients for a period of six months as per the computer

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 30 to 60yrs. 2. Patients having serum LDL cholesterol levels >160mg/dl. 3. Willingness to participate in the study. 4. Controlled hypertensive patients who are on antihypertensive treatment and who fulfill above mentioned 1st, 2nd & 3rd criteria. 5. Pre diabetic patients with fasting blood sugar >110 and

Exclusion criteria

Exclusion criteria: 1. Family H/O of coronary heart diseases, hypertriglyceridemia 2. Past history of any cardiac event. 3. Any known systemic illness (cancer, hepatic diseases, renal diseases, diabetes, HIV, any abnormality in LFT& KFT). 4. Patients on corticosteroids and hormonal treatment. 5. Excessive alcohol intake, who are taking 60 ml in case of males and 30 ml in case of female for last 1 yr. 6. Unable or unwilling to give informed consent. 7. Pregnant and lactating mother.

Design outcomes

Primary

MeasureTime frame
To evaluate the changes in LDL cholesterol levelsTimepoint: Month 3 and 6

Secondary

MeasureTime frame
To evaluate the changes in â?¢ Total Cholesterol (TC) at 3rd and 6th month from baseline. â?¢ Triglycerides (TGL) at 3rd and 6th month from baseline. â?¢ High Density lipoproteins (HDL) at 3rd and 6th month from baseline Timepoint: 3rd and 6th month

Countries

India

Contacts

Public ContactDr Varanasi Roja

Central Council for Research in Homoeopathy

oberai.praveen@gmail.com011-28525523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026